Investor Presentaiton slide image

Investor Presentaiton

OPERATING PERFORMANCE DEVELOPMENT ACROSS PRIVATE LARGE PORTFOLIO COMPANIES (CONT'D) 80 RETAIL (PHARMACY) REVENUE DEVELOPMENT +28.1% +18.3% EBITDA¹ DEVELOPMENT KEY DRIVERS Robust performance of the Retail (Pharmacy), reflecting overall improvement in economic activity and continuing expansion of the pharmacy chain. Same-store revenue growth at 14.8%, up 11.2 ppts y-o-y in 3Q21. Number of bills issued up 5.9% y-o-y to 7.4 million in 3Q21. Average bill size up 18.4% y-o-y to GEL 18.5 in 3Q21. GEL MILLION +31.7% +21.1% 193 160 147 478 442 566 +34.7% +24.7% 20 15 16 GEORGIA CAPITAL +16.5% 46 50 46 +7.3% 5.4 3Q19 3Q20 3Q21 9M19 9M20 9M21 3Q19 3Q20 3Q21 9M19 9M20 9M21 Added 32 pharmacies over the last 12 months, expanding from 309 to 341 stores Georgia Capital PLC | 1. Excluding IFRS 16. 38
View entire presentation